InsidersTradesSigma
Track the Varex Imaging Corp stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Varex Imaging Corp has logged 90 insider filings. Market capitalisation: €778m. The latest transaction was disclosed on 18 August 2026 (Levée d'options). Among the most active insiders: Honeysett Kimberley E.. All data is free.
90
Insider Decl.
n/a
Thresholds
€189,537
2 ops.
Buy Volume
€1m
15 ops.
Sell Volume
35Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,659 of 29,062 companies
34.9
score / 100
Value35
Quality35
FCF yld2.4%
Earn yld-9.0%
EV/EBITDA·
ROE4.6%
Gross mgn34%
Net mgn-8.3%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
Declarations90 total
3,974 sharesCommon StockSEC:0001681622-26-000071:0
1,145 shares@ US$18.49Common StockSEC:0001681622-26-000071:1
4,510 shares@ US$11.1417.9% of flowCommon StockSEC:0001592005-26-000005:0
8,483 sharesCommon StockSEC:0001681622-26-000014:0
8,483 sharesCommon StockSEC:0001278861-26-000004:0
8,483 sharesCommon StockSEC:0001217440-26-000002:0
8,483 sharesCommon StockSEC:0001701927-26-000003:0
8,483 sharesCommon StockSEC:0001532367-26-000002:0
10,339 sharesCommon StockSEC:0001413087-26-000003:0
4,664 sharesCommon StockSEC:0001681622-25-000127:0
4,664 sharesCommon StockSEC:0001681622-25-000126:0
26,652 sharesCommon StockSEC:0001681622-25-000125:0
6,665 sharesCommon StockSEC:0001681622-25-000123:0
7,063 sharesCommon StockSEC:0001681622-25-000122:0
3,174 shares@ US$12.340.0082% mcap50.0% of flowCommon StockSEC:0001681622-25-000093:0
3,000 shares@ US$10.4910.0% of flowCommon StockSEC:0001681622-25-000086:0
2,575 shares@ US$7.778.8% of flowCommon StockSEC:0001681622-25-000077:0
3,689 sharesCommon StockSEC:0001681622-25-000066:0
4,760 sharesCommon StockSEC:0001681622-25-000067:0
8,749 shares@ US$11.244.1% of flowCommon StockSEC:0001681622-25-000047:0
4,007 shares@ US$12.819.7% of flowCommon StockSEC:0001681622-25-000045:0
5,762 sharesCommon StockSEC:0001681622-25-000039:0
33,911 sharesCommon StockSEC:0001681622-25-000036:0
5,762 sharesCommon StockSEC:0001681622-25-000037:0
5,762 sharesCommon StockSEC:0001681622-25-000038:0
25 of 90 declarations
关于 Varex Imaging Corp
Varex Imaging Corp. (Nasdaq: VREX) 是一家总部位于美国的专业X射线成像技术公司，在美国纳斯达克市场上市。该公司设计、制造、销售和维修用于医疗成像系统以及工业和安全检查应用的关键组件和子系统。其核心产品组合包括X射线管、数字和光子计数探测器、图像处理软件、相关工作站以及其他高压和成像相关组件。实际上，Varex是为医院、安全检查和工业工作流程构建成像平台的原始设备制造商（OEM）的关键供应商。([vareximaging.com](https://www.vareximaging.com/news/varex-announces-successful-completion-of-debt-refinancing/?utm_source=openai)) 该公司的历史可追溯到1930年代的Eimac Products，随后是Varian X射线成像业务的增长。Varex随后作为一家独立公司分拆出来，以承载和扩展成像组件业务。这一传承使其在成像硬件和相关软件方面拥有悠久的运营记录和深厚的技术基础。其全球总部位于犹他州盐湖城，这使该公司处于美国创新走廊，拥有强大的制造和医疗技术联系。([vareximaging.com](https://www.vareximaging.com/about-us/?utm_source=openai)) 从竞争角度来看，Varex占据了一个具有战略重要性的利基市场。它主要不是系统供应商；相反，它提供核心成像构建模块，使其客户能够差异化其自身产品。这使得Varex在多个终端市场都具有相关性：医疗成像、非侵入式货物和车辆筛查以及选定的工业检查用途。这种模式提供了一定的多元化，但也使公司面临客户资本支出周期、技术采用和组件市场价格压力的影响。([vareximaging.com](https://www.vareximaging.com/news/varex-announces-successful-completion-of-debt-refinancing/?utm_source=openai)) 其产品系列涵盖CT管、平板探测器、光子计数探测器、图像处理软件、3D重建工具和货物检查系统。公司近期更新显示出更活跃的商业和财务背景：Varex于2025年5月宣布获得约25 million美元的货物检查订单，推出了用于高通量电动汽车电池检查的XRD 3131N探测器，并于2026年3月完成了债务再融资，总承诺额为490 million美元，于2031年到期。管理层表示，此次再融资应能提高财务灵活性并降低年化现金利息支出。这些事件凸显了该公司在产品执行和资产负债表修复方面的专注。([vareximaging.com](https://www.vareximaging.com/news/varex-announces-non-intrusive-cargo-inspection-systems-orders-valued-at-25-million/?utm_source=openai)) 对于国际投资者而言，Varex最好被视为一个利基医疗技术和工业成像基础设施公司，而非一家广泛的医疗保健公司。其对CT更换需求、安全筛查和电动汽车相关检查趋势的敞口可以支持其长期相关性，但该股票仍然对原始设备制造商需求、宏观周期和资本结构执行敏感。([sec.gov](https://www.sec.gov/Archives/edgar/data/1681622/000168162225000106/exhibit991-q425earningsrel.htm?utm_source=openai))
